# RFI Novel Antimalarial Drug Targets Canonical: https://abierto.us/opportunities/pandha25p0000015601rfinovelantimalarialdrugtargets - Solicitation number: PANDHA-25-P-0000-015601-RFI-Novel-Antimalarial-Drug-Targets - Notice type: Sources sought - Status: Closed. Deadline was May 19, 2025 at 10:00 AM EDT - Department: Department of Defense - Agency: Defense Health Agency (Dha) - Contracting office: Army Med Res Acq Activity (HT9425) - NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology) - Product or service code: AN13 Health R&D Services; Health Care Services; Experimental Development - First posted: May 7, 2025 - Last posted: May 7, 2025 - SAM.gov: https://sam.gov/workspace/contract/opp/b99aa7f3422c4c5b9266b318daa121f1/view ## Description This Request for Information (RFI)/Sources Sought (SS) Notice is for market research information and planning purposes only, and shall not be construed as a solicitation or as an obligation on the part of WRAIR, CIDR, VDB, or the Defense Health Agency (DHA) US Army Medical Research Acquisition Activity (USAMRAA). This non-commercial R&D requirement is expected to be a two-year study with a straight two-year Period of Performance (PoP) beginning September 30, 2025, and ending September 29, 2027. The work to be performed under this contract shall be performed off-site at Contractor facilities that may be located anywhere in the Continental United States (CONUS). See attached Request for information With DRAFT Statement of Work. ## Publications - May 7, 2025: Sources sought, due May 19, 2025 at 10:00 AM EDT. Notice b99aa7f3422c4c5b9266b318daa121f1. https://sam.gov/workspace/contract/opp/b99aa7f3422c4c5b9266b318daa121f1/view ## Points of contact - Jaclyn Svincek, jaclyn.p.svincek.civ@health.mil, 3016192189 - Jennifer Jackson, jennifer.c.jackson18.civ@health.mil --- Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/pandha25p0000015601rfinovelantimalarialdrugtargets.